TranS1 Reports Operating Results for the Third Quarter of 2012, Issues Fourth Quarter 2012 Guidance
WILMINGTON, N.C., Nov. 8, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lower lumbar region, today announced its financial results for the third quarter ended September 30, 2012.